How many stocks are there of Cochlear?
The current number of stocks of Cochlear is 65.72 M undefined.
Cochlear Stocks 2024
Cochlear Stocks
65.72 M
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
In 2024, Cochlear had 65.72 M outstanding stocks, a -0.27% change from the 65.9 M stocks in the previous year.
The Cochlear Stocks history
| YEAR | NUMBER OF STOCKS (undefined AUD) |
|---|---|
| 2030e | 65.72 |
| 2029e | 65.72 |
| 2028e | 65.72 |
| 2027e | 65.72 |
| 2026e | 65.72 |
| 2025e | 65.72 |
| 2024 | 65.72 |
| 2023 | 65.9 |
| 2022 | 65.77 |
| 2021 | 65.73 |
| 2020 | 59.63 |
| 2019 | 57.71 |
| 2018 | 57.6 |
| 2017 | 57.47 |
| 2016 | 57.24 |
| 2015 | 57.23 |
| 2014 | 57.1 |
| 2013 | 57 |
| 2012 | 56.9 |
| 2011 | 57 |
| 2010 | 56.6 |
| 2009 | 56 |
| 2008 | 55.8 |
| 2007 | 55.6 |
| 2006 | 55.1 |
| 2005 | 54.3 |
Cochlear shares outstanding AU000000COH5 · 898321
The number of shares was Cochlear in 2023 — This indicates how many shares 65.897 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Cochlear earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Cochlear's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Cochlear’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cochlear's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 54.3 M Aktien |
| 2006 | 55.1 M Aktien |
| 2007 | 55.6 M Aktien |
| 2008 | 55.8 M Aktien |
| 2009 | 56 M Aktien |
| 2010 | 56.6 M Aktien |
| 2011 | 57 M Aktien |
| 2012 | 56.9 M Aktien |
| 2013 | 57 M Aktien |
| 2014 | 57.1 M Aktien |
| 2015 | 57.23 M Aktien |
| 2016 | 57.24 M Aktien |
| 2017 | 57.47 M Aktien |
| 2018 | 57.6 M Aktien |
| 2019 | 57.71 M Aktien |
| 2020 | 59.63 M Aktien |
| 2021 | 65.73 M Aktien |
| 2022 | 65.77 M Aktien |
| 2023 | 65.9 M Aktien |
| 2024 | 65.72 M Aktien |
| 2025e | 65.72 M Aktien |
| 2026e | 65.72 M Aktien |
| 2027e | 65.72 M Aktien |
| 2028e | 65.72 M Aktien |
| 2029e | 65.72 M Aktien |
| 2030e | 65.72 M Aktien |
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Cochlear's Shares Outstanding
Cochlear's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Cochlear’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Cochlear’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Cochlear’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Cochlear stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Cochlear are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Cochlear evolved in recent years?
The number of shares of Cochlear has increased by -0.27% gesunken compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Cochlear as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Cochlear?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 5.42 AUD . This corresponds to a dividend yield of about 1.92 %. For the coming 12 months, Cochlear is expected to pay a dividend of 5.68 AUD.
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.92 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 26 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 5.68 AUD are expected. This corresponds to a dividend yield of 2.01 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 10/10/2024 amounting to 2.82 AUD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 4.058 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
